Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States

Maxwell C Messinger1, Nicklaus P Ashburn2, Joshua S Chait2

  • 1Department of Emergency Medicine, Wake Forest University School of Medicine, Winston-Salem, NC; Department of Family Medicine and Community Health, UMass Chan School of Medicine, Worcester, MA.

PubMed

Insights

Nearly 11 million people in the Southeast US face delayed access to percutaneous coronary intervention (PCI) due to long emergency medical services (EMS) transport times. This lack of timely treatment for ST-segment elevation myocardial infarction (STEMI) may increase health risks.

Area of Science:

  • Cardiovascular Medicine and Public Health
  • Health Services Research
  • Geographic Information Systems (GIS) in Healthcare

Background:

  • Timely percutaneous coronary intervention (PCI) is critical for ST-segment elevation myocardial infarction (STEMI) treatment, aiming for reperfusion within 90 minutes of first medical contact (FMC).
  • Long emergency medical services (EMS) transport times in rural Southeast US areas present a significant barrier to achieving guideline-recommended PCI treatment timelines.
  • Quantifying the population at risk of delayed PCI due to transport is essential for understanding and addressing healthcare disparities.

Purpose of the Study:

  • To estimate the number of Southeast US residents at risk of delayed primary PCI (PPCI) due to emergency medical services (EMS) transport times.
  • To identify geographic areas and populations disproportionately affected by long transport times to PPCI centers.

Main Methods:

  • A cross-sectional study utilized American Community Survey data and geographic information systems (GIS) to model EMS transport times to primary PCI (PPCI) centers in the Southeast US.
  • Analysis focused on estimating the number of residents living more than 30 and 60 minutes from PPCI centers, correlating with estimated first medical contact-to-device times.
  • Counties were assessed for the proportion of their population at risk of treatment delay (greater than 50% and 90% affected).

Main Results:

  • Approximately 10.87 million Southeast US residents (17.3% of the total population) are at risk of delayed PCI.
  • Over 1.27 million residents live more than 60 minutes away from a PPCI center, indicating significant access challenges.
  • 8.4% of counties have over 50% of their population at risk of delayed treatment, with 42.3% of these counties having over 90% of their population affected.

Conclusions:

  • A substantial population in the Southeast US lacks timely access to PCI, highlighting a critical healthcare access gap.
  • These findings suggest that geographic and transport-related barriers contribute to significant disparities in STEMI care.
  • The identified disparities in PCI access may lead to increased morbidity and mortality among affected populations.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...